IRIS Accounts Production v25.2.0.378 04698955 Board of Directors 1.1.24 31.12.24 31.12.24 Medium entities true false true true false false false true false Auditors Opinion These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. A Ordinary 0.10000 B Ordinary 0.10000 Preference Redeemable 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh046989552023-12-31046989552024-12-31046989552024-01-012024-12-31046989552022-12-31046989552023-01-012023-12-31046989552023-12-3104698955ns15:EnglandWales2024-01-012024-12-3104698955ns14:PoundSterling2024-01-012024-12-3104698955ns10:Director12024-01-012024-12-3104698955ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3104698955ns10:MediumEntities2024-01-012024-12-3104698955ns10:Audited2024-01-012024-12-3104698955ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-01-012024-12-3104698955ns10:Medium-sizedCompaniesRegimeForAccounts2024-01-012024-12-3104698955ns10:FullAccounts2024-01-012024-12-310469895512024-01-012024-12-3104698955ns10:OrdinaryShareClass22024-01-012024-12-3104698955ns10:OrdinaryShareClass32024-01-012024-12-3104698955ns10:OrdinaryShareClass42024-01-012024-12-3104698955ns10:Director22024-01-012024-12-3104698955ns10:Director32024-01-012024-12-3104698955ns10:Director42024-01-012024-12-3104698955ns10:Director52024-01-012024-12-3104698955ns10:Director62024-01-012024-12-3104698955ns10:Director72024-01-012024-12-3104698955ns10:CompanySecretary12024-01-012024-12-3104698955ns10:RegisteredOffice2024-01-012024-12-3104698955ns5:CurrentFinancialInstruments2024-12-3104698955ns5:CurrentFinancialInstruments2023-12-3104698955ns5:Non-currentFinancialInstruments2024-12-3104698955ns5:Non-currentFinancialInstruments2023-12-3104698955ns5:ShareCapital2024-12-3104698955ns5:ShareCapital2023-12-3104698955ns5:RetainedEarningsAccumulatedLosses2024-12-3104698955ns5:RetainedEarningsAccumulatedLosses2023-12-3104698955ns5:ShareCapital2022-12-3104698955ns5:RetainedEarningsAccumulatedLosses2022-12-3104698955ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-3104698955ns5:ShareCapital2024-01-012024-12-3104698955ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-3104698955ns5:NetGoodwill2024-01-012024-12-3104698955ns5:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-3104698955ns5:PlantMachinery2024-01-012024-12-3104698955ns5:FurnitureFittings2024-01-012024-12-3104698955ns5:MotorVehicles2024-01-012024-12-3104698955ns5:ComputerEquipment2024-01-012024-12-3104698955ns5:ReportableOperatingSegment12024-01-012024-12-3104698955ns5:ReportableOperatingSegment12023-01-012023-12-3104698955ns5:ReportableOperatingSegment22024-01-012024-12-3104698955ns5:ReportableOperatingSegment22023-01-012023-12-3104698955ns5:ReportableOperatingSegment32024-01-012024-12-3104698955ns5:ReportableOperatingSegment32023-01-012023-12-3104698955ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2024-01-012024-12-3104698955ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2023-01-012023-12-3104698955ns10:HighestPaidDirector2024-01-012024-12-3104698955ns10:HighestPaidDirector2023-01-012023-12-3104698955ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2024-01-012024-12-3104698955ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-01-012023-12-3104698955ns5:OwnedAssets2024-01-012024-12-3104698955ns5:OwnedAssets2023-01-012023-12-3104698955ns5:LeasedAssets2024-01-012024-12-3104698955ns5:LeasedAssets2023-01-012023-12-3104698955ns5:NetGoodwill2023-01-012023-12-3104698955ns5:HirePurchaseContracts2024-01-012024-12-3104698955ns5:HirePurchaseContracts2023-01-012023-12-3104698955ns5:NetGoodwill2023-12-3104698955ns5:PatentsTrademarksLicencesConcessionsSimilar2023-12-3104698955ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-3104698955ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-012024-12-3104698955ns5:NetGoodwill2024-12-3104698955ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3104698955ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-3104698955ns5:NetGoodwill2023-12-3104698955ns5:PatentsTrademarksLicencesConcessionsSimilar2023-12-3104698955ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-3104698955ns5:PlantMachinery2023-12-3104698955ns5:FurnitureFittings2023-12-3104698955ns5:MotorVehicles2023-12-3104698955ns5:ComputerEquipment2023-12-3104698955ns5:PlantMachinery2024-12-3104698955ns5:FurnitureFittings2024-12-3104698955ns5:MotorVehicles2024-12-3104698955ns5:ComputerEquipment2024-12-3104698955ns5:PlantMachinery2023-12-3104698955ns5:FurnitureFittings2023-12-3104698955ns5:MotorVehicles2023-12-3104698955ns5:ComputerEquipment2023-12-3104698955ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-12-3104698955ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-01-012024-12-3104698955ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-12-3104698955ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-12-3104698955ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3104698955ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3104698955ns5:WithinOneYearns5:HirePurchaseContracts2024-12-3104698955ns5:WithinOneYearns5:HirePurchaseContracts2023-12-3104698955ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-12-3104698955ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2023-12-3104698955ns5:HirePurchaseContracts2024-12-3104698955ns5:HirePurchaseContracts2023-12-3104698955ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-12-3104698955ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2023-12-3104698955ns5:WithinOneYear2024-12-3104698955ns5:WithinOneYear2023-12-3104698955ns5:BetweenOneFiveYears2024-12-3104698955ns5:BetweenOneFiveYears2023-12-3104698955ns5:AllPeriods2024-12-3104698955ns5:AllPeriods2023-12-3104698955ns5:DeferredTaxation2023-12-3104698955ns5:DeferredTaxation2024-12-3104698955ns10:OrdinaryShareClass22024-12-3104698955ns10:OrdinaryShareClass32024-12-3104698955ns5:RetainedEarningsAccumulatedLosses2023-12-31
REGISTERED NUMBER: 04698955 (England and Wales)













STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

SYCHEM LIMITED

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024




Page

Company Information 1

Strategic Report 2

Report of the Directors 4

Report of the Independent Auditor 6

Income Statement 10

Other Comprehensive Income 11

Balance Sheet 12

Statement of Changes in Equity 13

Notes to the Financial Statements 14


SYCHEM LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: M Barnes
C Wreyford
T J Barnes
D A Harding
L Barnes
A S Faulkner
R H Clarke





SECRETARY: T J Barnes





REGISTERED OFFICE: Sutherland House
1759 London Road
Leigh On Sea
Essex
SS9 2RZ





BUSINESS ADDRESS: 3 Mayflower Close
Chandlers Ford
Hampshire
SO53 4BU





REGISTERED NUMBER: 04698955 (England and Wales)





AUDITOR: affinia
Sutherland House
1759 London Road
Leigh On Sea
Essex
SS9 2RZ

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The directors present their strategic report for the year ended 31 December 2024.

Sychem Limited is a private limited company based in the UK that specializes in providing disinfection, sterilization, and decontamination solutions. With over 40 years of experience, the company serves a range of sectors, including healthcare, pharmaceuticals, and laboratories. Sychem's business model revolves around a comprehensive, end-to-end approach, which includes the supply of capital equipment (such as autoclaves and washer-disinfectors), specialist chemicals, and consumables, as well as providing UKAS-accredited validation, maintenance, and aftersales support.

FAIR REVIEW OF BUSINESS
Market constraints made the market for capital projects challenging for Sychem throughout the year however, the need for maintenance and service by its customers increased during the year.

With the variability of capital projects the business has made it's key focus on the growth of it's service offerings in all of the market place that it is active in.

PRINCIPAL RISKS AND UNCERTAINTIES
Regulatory risk

The group's products and machines are manufactured to the highest quality standards to maintain industry accreditations and comply with all relevant laws and licenses.

Quality management is therefore a key priority for the business and regular monitoring is carried out. Any failings could lead to litigation and reputational damage.

The company has rigorous recruitment procedures to ensure technical staff and engineers have the appropriate qualifications and experience. Ongoing training programmes are in place.

Economic conditions and government policy

Customer appetite for capital investment will be partly influenced by macro economic factors such as interest rates, availability of finance, political stability and government tax policy.

The company manages its exposure to foreign exchange fluctuations by taking out hedging contracts where suitable.

Competition

The company remains ever alert to new entrants to the market.

The company prides itself on its reputation with customers and suppliers and by maintaining good relations throughout the supply chain, the group is able to offer an excellent level of service to clients thereby ensuring repeat custom.

Bank funding

The company does utilise bank funding for capital investment or short term working capital requirements. It maintains a good relationship with the bank and ensures that it meets it obligations under any covenant agreements.

FUTURE DEVELOPMENTS
The company will continue to work with it's extensive customer base to deliver capital projects, repair services and consumables. The residual supply of medical equipment left over from the closure of a fellow subsidiary, Sychem Surgical Limited, has been transferred to Sychem Ltd during the period since the balance sheet date. .

Sychem continues to look for opportunities to drive growth and expand its operations in strategic locations.


SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

KEY PERFORMANCE INDICATORS
The key performance indicators of the company are:
Turnover decreased by 16%
Gross profit margin 52% (2023: 48%)
EBITDA - loss - £301,656 (2023: Profit- £747,119)
Shareholders funds decreased by 29%

ON BEHALF OF THE BOARD:





A S Faulkner - Director


30 September 2025

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2024

The directors present their report with the financial statements of the company for the year ended 31 December 2024.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of sale and service of equipment to the medical and laboratory industries

DIVIDENDS
No interim dividends were paid during the year on any of the shares.

No dividends will be distributed for the year ended 31 December 2024.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2024 to the date of this report.

M Barnes
C Wreyford
T J Barnes
D A Harding
L Barnes

Other changes in directors holding office are as follows:

A S Faulkner - appointed 2 January 2024
R H Clarke - appointed 2 January 2024

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditor is unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditor is aware of that information.

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2024


AUDITOR
The auditor, affinia, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





A S Faulkner - Director


30 September 2025

REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF
SYCHEM LIMITED

Qualified opinion
I have audited the financial statements of Sychem Limited (the 'company') for the year ended 31 December 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion, except for the possible effect on the corresponding figures of the matters described in the Basis for Qualified Opinion paragraph, the financial statements:

- give a true and fair view of the state of the company's affairs as at 31st December 2024 and of its profit for the year then ended;
- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
- have been prepared in accordance with the requirements of the Companies Act 2006 .

Basis for qualified opinion
We were not appointed as auditor of the company until after 31 December 2022 and thus did not observe the counting of physical inventories or verify the status and condition of work in progress on projects as at the end of that year. We were unable to satisfy ourselves by alternative means concerning the inventory quantities of £957,133 held at 31st December 2022 by using other audit procedures.

We were therefore unable to determine whether there was any consequential effect on the cost of sales for the year ended 31st December 2023. Our audit opinion on the financial statements for the period ended 31st December 2023 was modified accordingly. Our opinion on the current period's financial statements is also modified because of the possible effect of this matter on the comparability of the current period's figures and the corresponding figures.

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified opinion.

Conclusions relating to going concern
In auditing the financial statements, I have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work I have performed, I have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

My responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and my Report of the Auditor thereon.

My opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in my report, I do not express any form of assurance conclusion thereon.

In connection with my audit of the financial statements, my responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or my knowledge obtained in the audit or otherwise appears to be materially misstated. If I identify such material inconsistencies or apparent material misstatements, I am required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work I have performed, I conclude that there is a material misstatement of this other information, I am required to report that fact. I have nothing to report in this regard.

REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF
SYCHEM LIMITED


Opinions on other matters prescribed by the Companies Act 2006
In my opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which I am required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, I have not identified material misstatements in the Strategic Report or the Report of the Directors.

In respect solely of the limitation on our work relating to corresponding figures referred to above:
- we have not obtained all the information and explanations that we considered necessary for the purpose of our audit; and
- we were unable to determine whether adequate accounting records had been maintained.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made.
- the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption from the requirement to prepare a Strategic Report or in preparing the Report of the Directors.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page four, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF
SYCHEM LIMITED


Auditor's responsibilities for the audit of the financial statements
My objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditor that includes my opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which my procedures are capable of detecting irregularities, including fraud is detailed below:

We obtained an understanding of the legal and regulatory framework applicable to the entity through written and verbal communication. In addition, we drew on our professional knowledge of the industry to aid our understanding.

We obtained an understanding of the systems in place designed to ensure compliance with the relevant legislation and evaluated whether these are sufficient or alternatively whether the risk of non-compliance is heightened. We also made specific enquiries of management and those charged with governance as to whether there have been any known instances of non-compliance and the results of their risk assessment.

We briefed the identified laws and regulations to our audit team, ensuring they are aware of those considered significant in nature. At the same time, the responsible individual considered whether the engagement team has the collective competence to recognise non-compliance with laws and regulations.

The company's financial statements are directly affected by company law, applicable financial reporting standards and tax legislation. Our audit tests are designed to provide sufficient expectation that we will highlight instances of non-compliance.

Owing to the nature of the entity's trade, we have identified that non-compliance with specific legislation has the potential to materially affect the disclosures in the financial statements by way of litigation or fines and penalties. Such legislation includes GDPR, employment and health and safety legislation.

In addition to holistically considering where and how fraud may occur within the company, the following specific procedures were also undertaken:

- Scrutinising journal entries, in particular those crediting cash or a revenue account; journal entries with unusual nominal combinations or journal entries posted by management;

- Evaluating assumptions made by management, in particular where these involve material accounting estimates;

- Making sure our samples include an appropriate number of random of entries selected on a random basis;

- Undertaking analytical procedures with a view to identifying unusual movements in account balances which could be indicative of fraud.

We did not identify nor do we suspect any material fraudulent activity having undertaken the above procedures.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of my responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of my Report of the Auditor.

REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF
SYCHEM LIMITED


Use of my report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. My audit work has been undertaken so that I might state to the company's members those matters I am required to state to them in a Report of the Auditor and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the company and the company's members as a body, for my audit work, for this report, or for the opinions I have formed.




Graham Powling FCA (Senior Statutory Auditor)
for and on behalf of affinia
Sutherland House
1759 London Road
Leigh On Sea
Essex
SS9 2RZ

30 September 2025

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

INCOME STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024

2024 2023
Notes £    £    £    £   

TURNOVER 3 10,459,603 12,493,500

Cost of sales 5,050,585 6,437,797
GROSS PROFIT 5,409,018 6,055,703

Distribution costs 23,747 16,330
Administrative expenses 5,686,927 5,292,254
5,710,674 5,308,584
OPERATING (LOSS)/PROFIT 5 (301,656 ) 747,119

Interest receivable and similar income 1,836 1,860
(299,820 ) 748,979

Interest payable and similar expenses 7 16,348 11,037
(LOSS)/PROFIT BEFORE TAXATION (316,168 ) 737,942

Tax on (loss)/profit 8 (25,004 ) 254,447
(LOSS)/PROFIT FOR THE FINANCIAL
YEAR

(291,164

)

483,495

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024

2024 2023
Notes £    £   

(LOSS)/PROFIT FOR THE YEAR (291,164 ) 483,495


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

(291,164

)

483,495

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 49,484 57,705
Tangible assets 10 423,380 527,699
472,864 585,404

CURRENT ASSETS
Stocks 11 1,310,254 1,502,661
Debtors 12 2,532,936 3,411,750
Cash at bank 125,803 46,988
3,968,993 4,961,399
CREDITORS
Amounts falling due within one year 13 2,412,152 2,671,209
NET CURRENT ASSETS 1,556,841 2,290,190
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,029,705

2,875,594

CREDITORS
Amounts falling due after more than one
year

14

(86,765

)

(168,486

)

PROVISIONS FOR LIABILITIES 18 (101,682 ) (126,686 )
NET ASSETS 1,841,258 2,580,422

CAPITAL AND RESERVES
Called up share capital 19 2,000 450,000
Retained earnings 20 1,839,258 2,130,422
SHAREHOLDERS' FUNDS 1,841,258 2,580,422

The financial statements were approved by the Board of Directors and authorised for issue on 30 September 2025 and were signed on its behalf by:





A S Faulkner - Director


SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 January 2023 450,000 1,646,927 2,096,927

Changes in equity
Total comprehensive income - 483,495 483,495
Balance at 31 December 2023 450,000 2,130,422 2,580,422

Changes in equity
Issue of share capital (448,000 ) - (448,000 )
Total comprehensive income - (291,164 ) (291,164 )
Balance at 31 December 2024 2,000 1,839,258 1,841,258

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1. STATUTORY INFORMATION

Sychem Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Financial Reporting Standard 102 - reduced disclosure exemptions
The company has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

the requirements of Section 7 Statement of Cash Flows.

Significant judgements and estimates
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2008, is being amortised evenly over its estimated useful life of twenty years.

Research & development
Research & Development costs are capitalised and amortised over the anticipated earning period of the technology commencing in the year in which the first revenues are received

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Free on Loan - 20% on cost

Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 "Basic Financial Instruments" and Section 12 "Other Financial Instruments Issues" of FRS 102 to all its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets:
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities:
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financing liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective rate of interest.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment due within one year or less. If not they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Contract revenue and work-in-progress
Contract revenue is recognised when the revenue can be separated from the sale of goods and the outcome of the contract can be estimated reliably. Costs initially incurred securing the contract are expensed to the profit and loss account.

The extent to which contract revenue is recognised is dependent upon the stage of completion. The company recognises revenue based on the physical proportion of the contact completed. At such time this cannot be measured reliably, the company recognises revenue to the extent contract costs are incurred.

Amounts due from customers for contract work is recorded as work-in-progress and included within trade and other debtors. Amounts due to customers for contract work is recorded as deferred income and included in trade and other creditors.

3. TURNOVER

The turnover and loss (2023 - profit) before taxation are attributable to the one principal activity of the company.

An analysis of turnover by class of business is given below:

2024 2023
£    £   
Servicing 4,373,841 4,041,357
Consumables and cleaning 1,663,926 1,377,936
Equipment sales 4,421,836 7,074,207
10,459,603 12,493,500

4. EMPLOYEES AND DIRECTORS
2024 2023
£    £   
Wages and salaries 2,808,130 2,722,450
Social security costs 339,519 306,214
Other pension costs 244,846 201,797
3,392,495 3,230,461

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

4. EMPLOYEES AND DIRECTORS - continued

The average number of employees during the year was as follows:
2024 2023

Employees 66 61

2024 2023
£    £   
Directors' remuneration 421,708 387,264
Directors' pension contributions to money purchase schemes 61,333 50,400

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 5 3

Information regarding the highest paid director is as follows:
2024 2023
£    £   
Emoluments etc 123,890 122,510
Pension contributions to money purchase schemes 7,200 7,200

5. OPERATING (LOSS)/PROFIT

The operating loss (2023 - operating profit) is stated after charging/(crediting):

2024 2023
£    £   
Hire of plant and machinery 13,560 24,724
Other operating leases - 1,740
Depreciation - owned assets 51,351 51,557
Depreciation - assets on hire purchase contracts 53,989 34,852
(Profit)/loss on disposal of fixed assets (2,854 ) 269
Goodwill amortisation 8,221 8,220
Auditors' remuneration 20,500 19,500
Auditors' remuneration for non audit work 33,841 27,777

6. EXCEPTIONAL ITEMS
2024 2023
£    £   
Loan write off (66,130 ) (5,882 )

In the prior year a loan to the value of £5,882 due from a company under the common control of one of the company's directors was written off.

In the year a loan to the value of £66,130 due from a group company was written off.

7. INTEREST PAYABLE AND SIMILAR EXPENSES
2024 2023
£    £   
Hire purchase 16,348 11,037

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

8. TAXATION

Analysis of the tax (credit)/charge
The tax (credit)/charge on the loss for the year was as follows:
2024 2023
£    £   
Current tax:
UK corporation tax - 154,639

Deferred tax (25,004 ) 99,808
Tax on (loss)/profit (25,004 ) 254,447

9. INTANGIBLE FIXED ASSETS
Patents
and Development
Goodwill licences costs Totals
£    £    £    £   
COST
At 1 January 2024
and 31 December 2024 164,405 19,722 147,411 331,538
AMORTISATION
At 1 January 2024 126,422 - 147,411 273,833
Amortisation for year 8,221 - - 8,221
At 31 December 2024 134,643 - 147,411 282,054
NET BOOK VALUE
At 31 December 2024 29,762 19,722 - 49,484
At 31 December 2023 37,983 19,722 - 57,705

10. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Motor Free on
machinery fittings vehicles Loan Totals
£    £    £    £    £   
COST
At 1 January 2024 521,716 80,961 353,405 10,000 966,082
Additions 4,900 2,070 - - 6,970
Disposals - - (30,235 ) (10,000 ) (40,235 )
At 31 December 2024 526,616 83,031 323,170 - 932,817
DEPRECIATION
At 1 January 2024 290,760 44,373 93,250 10,000 438,383
Charge for year 35,228 5,799 64,313 - 105,340
Eliminated on disposal - - (24,286 ) (10,000 ) (34,286 )
At 31 December 2024 325,988 50,172 133,277 - 509,437
NET BOOK VALUE
At 31 December 2024 200,628 32,859 189,893 - 423,380
At 31 December 2023 230,956 36,588 260,155 - 527,699

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

10. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST
At 1 January 2024 300,155
Disposals (30,235 )
At 31 December 2024 269,920
DEPRECIATION
At 1 January 2024 81,296
Charge for year 53,989
Eliminated on disposal (24,286 )
At 31 December 2024 110,999
NET BOOK VALUE
At 31 December 2024 158,921
At 31 December 2023 218,859

11. STOCKS
2024 2023
£    £   
Stocks 993,485 986,950
Work-in-progress 316,769 515,711
1,310,254 1,502,661

12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 1,434,001 1,912,897
Amounts owed by group undertakings 927,518 704,666
Other Debtors 1,122 -
Rent deposit - 4,450
Sundry debtors 3,000 -
Purchase ledger debit balances - 1,215
Related non-group loan account - 621,914
Accrued income 87,462 -
Prepayments 79,833 166,608
2,532,936 3,411,750

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts (see note 15) - 26,805
Hire purchase contracts (see note 16) 81,721 43,886
Trade creditors 1,223,421 1,364,314
Amounts owed to group undertakings - 28,481
Tax 190,255 190,255
Social security and other taxes 89,502 100,387
Pension Creditor 17,505 15,851
Sales ledger credit balances - 39,681
VAT 186,624 292,833
Other creditors 39,570 50,000
Directors' current accounts - 33,745
Deferred Income 522,794 393,094
Accrued expenses 60,760 91,877
2,412,152 2,671,209

14. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Hire purchase contracts (see note 16) 86,765 168,486

15. LOANS

An analysis of the maturity of loans is given below:

2024 2023
£    £   
Amounts falling due within one year or on demand:
Bank overdrafts - 26,805

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

16. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase
contracts
2024 2023
£    £   
Gross obligations repayable:
Within one year 94,998 59,787
Between one and five years 96,977 191,973
191,975 251,760

Finance charges repayable:
Within one year 13,277 15,901
Between one and five years 10,212 23,487
23,489 39,388

Net obligations repayable:
Within one year 81,721 43,886
Between one and five years 86,765 168,486
168,486 212,372

Non-cancellable
operating leases
2024 2023
£    £   
Within one year 256,736 248,579
Between one and five years 498,611 630,467
755,347 879,046

17. SECURED DEBTS

The company stands as guarantor for amounts advanced to group companies by the National Westminster Bank PLC. Accordingly the National Westminster Bank PLC holds fixed and floating charges over all of the company's assets.

18. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 101,682 126,686

Deferred
tax
£   
Balance at 1 January 2024 126,686
Deferred tax (25,004 )
Balance at 31 December 2024 101,682

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

19. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
10,000 A Ordinary 10p 1,000 1,000
10,000 B Ordinary 10p 1,000 1,000
NIL Preference Redeemable £1 - 448,000
2,000 450,000

During the period under review, all 448,000 £1 redeemable preference shares held by the parent company were redeemed.

20. RESERVES
Retained
earnings
£   

At 1 January 2024 2,130,422
Deficit for the year (291,164 )
At 31 December 2024 1,839,258

21. CONTINGENT LIABILITIES

In a previous accounting period HM Revenue and Customs opened enquiries into the Research and Development claims for the Corporation Tax periods ending 31st December 2020, 31st December 2021 and 31st December 2022. The directors had engaged tax consultants to defend these enquiries. After the reporting period HMRC determined that the Research and Development claims were valid and accepted.

22. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Invoices totalling £85,766 (2023: £31,118) were raised to subsidiaries in the same group. At the balance sheet date the amount outstanding was £10,505 (2023: £7,763), included in trade and other debtor.

Invoices totalling £128,452 (2023: £84,867) were received from subsidiaries in the same group. At the balance sheet date the amount outstanding was £2,538 (2023: £41,704), included in trade and other creditors.

Invoices totalling £472,890 (2023: £448,040) were received from entities under common control. At the balance sheet date the amount outstanding was £39,580 (2023: £51,580), included in trade and other creditors.

Invoices totalling £4,412 (2023: Nil) were raised to entities under common control. At the balance sheet date the balance date the amount outstanding was £792 (2023: £50,177).

In the year the company written-off a loan due from a subsidiary of the same group. The amount written-off was £66,130 and has been included in the profit and loss account.

The company's parent company is TS Group International Limited, whose registered office is Sutherland House, 1759 London Road, Leigh-on-sea, Essex, SS9 2RZ.

TS Group International Limited draws up consolidated financial statements.

SYCHEM LIMITED (REGISTERED NUMBER: 04698955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

22. RELATED PARTY DISCLOSURES - continued

The ultimate controlling party is M Barnes.

23. AUDITOR LIABILITY LIMITATION AGREEMENT

On 30th July 2025 the directors resolved a Liability Limitation Agreement with it's Auditors. It was agreed that £2,000,000 represents a fair maximum to the auditors liability in the event of any one claim arising in respect of the audit.

24. SHARE-BASED PAYMENT TRANSACTIONS

The company's parent, TS Group International Limited created an equity-settled share option scheme which employees of the company can participate in. This scheme is an Enterprise Management Incentive Plan approved by HMRC. Each option has a maximum term of 10 years from the grant date, and each option vests only upon an exit event. Employees must remain in employment until the exit event to retain their share options.

1,935 share options were granted on 16 September 2024 and all were outstanding at the balance sheet date. The valuation of the shares was approved by HMRC. Due to uncertainty around the date of an exit event and the market value of the shares at the grant date, no amount was recognised in the profit or loss in the current year in relation to the vesting of the shares, on the basis that a recognition of costs will occur once the exit condition and market value of shares are more certain.